AK Alrosa PAO
MOEX:ALRS
to continue ALRS research
to continue ALRS research
You've reached your weekly stock limit.
Sign UpAK Alrosa PAO?
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
Banking
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
Technology
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
US |
![]() |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
US |
![]() |
Visa Inc
NYSE:V
|
Technology
|
CN |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
Beverages
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
Retail
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
Energy
|
We'll email you a reminder when the closing price reaches USD.
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
44.59
72.19
|
Price Target |
|
We'll email you a reminder when the closing price reaches RUB.
Choose the stock you wish to monitor with a price alert.
![]() |
Johnson & Johnson
NYSE:JNJ
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
US |
![]() |
Nike Inc
NYSE:NKE
|
US |
![]() |
Visa Inc
NYSE:V
|
US |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
What unique competitive advantages
does AK Alrosa PAO hold over its rivals?
What risks and challenges
does AK Alrosa PAO face in the near future?
Is it considered overvalued or undervalued
based on the latest financial data?
Provide an overview of the primary business activities
of AK Alrosa PAO.
Provide an overview of the primary business activities
of AK Alrosa PAO.
What unique competitive advantages
does AK Alrosa PAO hold over its rivals?
What risks and challenges
does AK Alrosa PAO face in the near future?
Is it considered overvalued or undervalued
based on the latest financial data?
Show all valuation multiples
for AK Alrosa PAO.
Provide P/S
for AK Alrosa PAO.
Provide P/E
for AK Alrosa PAO.
Provide P/OCF
for AK Alrosa PAO.
Provide P/FCFE
for AK Alrosa PAO.
Provide P/B
for AK Alrosa PAO.
Provide EV/S
for AK Alrosa PAO.
Provide EV/GP
for AK Alrosa PAO.
Provide EV/EBITDA
for AK Alrosa PAO.
Provide EV/EBIT
for AK Alrosa PAO.
Provide EV/OCF
for AK Alrosa PAO.
Provide EV/FCFF
for AK Alrosa PAO.
Provide EV/IC
for AK Alrosa PAO.
Show me price targets
for AK Alrosa PAO made by professional analysts.
What are the Revenue projections
for AK Alrosa PAO?
How accurate were the past Revenue estimates
for AK Alrosa PAO?
What are the Net Income projections
for AK Alrosa PAO?
How accurate were the past Net Income estimates
for AK Alrosa PAO?
What are the EPS projections
for AK Alrosa PAO?
How accurate were the past EPS estimates
for AK Alrosa PAO?
What are the EBIT projections
for AK Alrosa PAO?
How accurate were the past EBIT estimates
for AK Alrosa PAO?
Compare the revenue forecasts
for AK Alrosa PAO with those of its competitors based on recent analyst estimates.
Compare the intrinsic valuations
of AK Alrosa PAO and its key competitors using the latest financial data.
Compare historical revenue growth rates
of AK Alrosa PAO against its competitors.
Analyze the profit margins
(gross, operating, and net) of AK Alrosa PAO compared to its peers.
Compare the P/E ratios
of AK Alrosa PAO against its peers.
Discuss the investment returns and shareholder value creation
comparing AK Alrosa PAO with its peers.
Analyze the financial leverage
of AK Alrosa PAO compared to its main competitors.
Show all profitability ratios
for AK Alrosa PAO.
Provide ROE
for AK Alrosa PAO.
Provide ROA
for AK Alrosa PAO.
Provide ROIC
for AK Alrosa PAO.
Provide ROCE
for AK Alrosa PAO.
Provide Gross Margin
for AK Alrosa PAO.
Provide Operating Margin
for AK Alrosa PAO.
Provide Net Margin
for AK Alrosa PAO.
Provide FCF Margin
for AK Alrosa PAO.
Show all solvency ratios
for AK Alrosa PAO.
Provide D/E Ratio
for AK Alrosa PAO.
Provide D/A Ratio
for AK Alrosa PAO.
Provide Interest Coverage Ratio
for AK Alrosa PAO.
Provide Altman Z-Score Ratio
for AK Alrosa PAO.
Provide Quick Ratio
for AK Alrosa PAO.
Provide Current Ratio
for AK Alrosa PAO.
Provide Cash Ratio
for AK Alrosa PAO.
What is the historical Revenue growth
over the last 5 years for AK Alrosa PAO?
What is the historical Net Income growth
over the last 5 years for AK Alrosa PAO?
What is the current Free Cash Flow
of AK Alrosa PAO?
Discuss the annual earnings per share (EPS)
trend over the past five years for AK Alrosa PAO.
EV/EBITDA
Enterprise Value to EBITDA
Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.
Market Cap | EV/EBITDA | ||||
---|---|---|---|---|---|
RU |
A
|
AK Alrosa PAO
MOEX:ALRS
|
324.6B RUB | 5.1 | |
ZA |
A
|
Anglo American Platinum Ltd
JSE:AMS
|
215.6B Zac | 0 |
|
ZA |
I
|
Impala Platinum Holdings Ltd
JSE:IMP
|
133.2B Zac | 0 |
|
ZA |
S
|
Sibanye Stillwater Ltd
JSE:SSW
|
87.5B Zac | 0 |
|
ZA |
N
|
Northam Platinum Holdings Ltd
JSE:NPH
|
71.7B Zac | 0 |
|
ZA |
R
|
Royal Bafokeng Platinum Ltd
JSE:RBP
|
36.7B Zac | 0 |
|
MX |
![]() |
Fresnillo PLC
LSE:FRES
|
10.6B GBP | -19.8 |
|
MX |
I
|
Industrias Penoles SAB de CV
BMV:PE&OLES
|
191.4B MXN | 4.5 |
|
CY |
T
|
Tharisa PLC
JSE:THA
|
5.7B Zac | 0 |
|
CN |
![]() |
Sino-Platinum Metals Co Ltd
SSE:600459
|
11.4B CNY | 16.4 |
|
CA |
![]() |
Silvercrest Metals Inc
TSX:SIL
|
2.2B CAD | 8.6 |
|
EBITDA Growth | EV/EBITDA to Growth | |||||
---|---|---|---|---|---|---|
RU |
A
|
AK Alrosa PAO
MOEX:ALRS
|
Average EV/EBITDA:
8.7
5.1
|
N/A | N/A | |
ZA |
A
|
Anglo American Platinum Ltd
JSE:AMS
|
Not Available |
28%
|
N/A |
|
ZA |
I
|
Impala Platinum Holdings Ltd
JSE:IMP
|
Not Available |
30%
|
N/A |
|
ZA |
S
|
Sibanye Stillwater Ltd
JSE:SSW
|
Not Available |
19%
|
N/A |
|
ZA |
N
|
Northam Platinum Holdings Ltd
JSE:NPH
|
Not Available |
29%
|
N/A |
|
ZA |
R
|
Royal Bafokeng Platinum Ltd
JSE:RBP
|
Not Available |
-5%
|
N/A |
|
MX |
![]() |
Fresnillo PLC
LSE:FRES
|
Negative Multiple: -19.8 |
5%
|
N/A |
|
MX |
I
|
Industrias Penoles SAB de CV
BMV:PE&OLES
|
4.5
|
2%
|
2.2 |
|
CY |
T
|
Tharisa PLC
JSE:THA
|
Not Available |
5%
|
N/A |
|
CN |
![]() |
Sino-Platinum Metals Co Ltd
SSE:600459
|
16.4
|
N/A | N/A |
|
CA |
![]() |
Silvercrest Metals Inc
TSX:SIL
|
8.6
|
4%
|
2.2 |
|
EV/EBITDA Forward Multiples
Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.